LexDanaLexDanabeta
Inventor

TAE HEE HA

Inventor
KR

Overview

2→
Patents
2024–2025
Patent span
Chemistry
Primary field (CPC C)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07BGeneral methods of organic chemistry22%
C07DHeterocyclic compounds22%
C07CAcyclic or carbocyclic compounds11%
PatentTitleYear
12,227,510Crystal form of acid addition salt of furopyrimidine compound202511,883,402Crystalline forms of a quinazoline compound and its hydrochloride salts2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024–2025Patents assigned to HANMI PHARMACEUTICAL CO LTD (2)· patent assignee history
2024Patents assigned to SPECTRUM PHARMACEUTICALS INC (1)· patent assignee history
2024–2025Based in KR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
HANMI PHARMACEUTICAL CO LTD22024–2025
SPECTRUM PHARMACEUTICALS INC12024
Locations
LocationPatentsSpan
KR22024–2025